The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Hormonal aspects of epithelial ovarian cancer: review of epidemiological evidence
Open accessAbstract
Globally, ovarian cancer is the sixth most common cancer among women. The annual incidence rates of ovarian cancer, age-adjusted to the world population, differ among geographic areas. Especially high rates are reported in Scandinavia (15/100 000). In Northern America and western Europe the rates are intermediate (10/100 000), while developing countries and Japan have low rates (3/100 000) (Parkin et al., 1993). The life-time risk for a woman to develop ovarian cancer is 1–2% in high incidence areas. As most cases are diagnosed at an advanced stage the prognosis is poor, with 5-year survival rates less than 40%. Annually more than 100 000 women are estimated to die from the disease (Pisani et al., 1993). The vast majority of epithelial ovarian cancers are sporadic, while 5–10% are estimated to be inherited (Narod et al., 1994). The breast–ovarian cancer syndrome is the most common inherited type and has been linked to germline mutations in the BRCA1 tumour-suppressor gene (Narod et al., 1991), which was cloned in 1994 (Miki et al., 1994). The estimated risk among BRCA1 carriers to develop an ovarian malignancy by age 70 is 63%, and the prevalence of carriers in the general population is 1/800 (Ford & Easton, 1995). Epithelial ovarian tumours, germ cell tumours and sex cord/stromal tumours are the major types of ovarian tumours. Epithelial ovarian tumours are derived from the surface epithelium and typically constitute 80–90% of ovarian malignancies. Of the epithelial tumours, approximately 15% are of borderline malignant potential while the rest are invasive cancers. There are several histopathological subgroups of epithelial ovarian cancers (Slotman & Rao, 1988). In an English case–control study the epithelial ovarian cancers were distributed as follows: serous adenocarcinoma (43%), mucinous adenocarcinoma (15%), endometroid adenocarcinoma (22%), clear cell adenocarcinoma (5%) and mixed or undifferentiated tumours (14%) (Booth et al., 1989). Similar results have been reported in a recent Norwegian project (Björge et al., 1997). This review will focus on how reproductive factors, hormonal contraceptives, hormone replacement therapy, hormonal infertility treatment and common gynecological operations are related to epithelial ovarian cancer epidemiology. First, some possible aetiological aspects will be discussed. The causes of ovarian cancer are poorly understood. Reproductive hormones are thought to be involved in the aetiology. For many years the ‘incessant ovulation’ (Fathalla, 1971) and ‘gonadotrophin’ hypotheses (Stadel, 1975) have been connected to ovarian carcinogenesis. These hypotheses find support in epidemiological research, and recent progress in molecular biology augments the insight on possible aetiological mechanisms at the cellular level (Godwin et al., 1993; Boyd & Rubin, 1997). Other hypotheses explore the retrograde transport of contaminants (Cramer et al., 1982) or endogenous carcinogens (Cramer & Xu, 1995) through the Fallopian tubes. A new hypothesis proposes a pregnancy-dependent clearance of transformed malignant cells from the ovaries (Adami et al., 1994). The ‘incessant ovulation’ hypothesis suggests that the risk of epithelial ovarian cancer increases with the number of ovulations, as the traumatized epithelium of ruptured follicles is recurrently repaired and exposed to oestrogen-rich follicular fluid. Growth factors are believed to influence post-ovulatory repair, and impaired regulation of growth factors may be involved in malignant transformation. Epithelial growth factor (EGF) stimulated growth in several human ovarian cancer cell-lines (Berchuck et al., 1990). Cells from epithelial ovarian cancers frequently express the EGF transmembrane receptor (Bauknecht et al., 1988; Berchuck et al., 1991; Rodriguez et al., 1991; Ilekis et al., 1997) and also secrete growth factors (Berchuck et al., 1990), indicating the possibility of growth regulatory autocrine loops. Oestrogen has been shown to be mitogenic to ovarian epithelium (Nash et al., 1989), an effect possibly mediated through altered growth factor levels. Local steroid production has been found in human epithelial ovarian tumours (Ridderheim et al., 1993; Abrahamsson et al., 1997), and steroid receptors are present in many ovarian tumours. In a review 62% of malignant ovarian tumours contained receptors for oestrogen, 49% for progesterone, 69% for androgen, while 49% of the tumours had both oestrogen and progesterone receptors (Rao & Slotman, 1991). Recent studies also report a high prevalence of androgen receptors (Ilekis et al., 1997). The exact biological relevance of local hormone production and expression of steroid receptors in ovarian cancers is still unresolved. Cytokines also seem to regulate both normal and malignant ovarian epithelium (Malik & Balkwill, 1991). In support of the ‘incessant ovulation’ hypothesis, experiments on rat surface epithelial ovarian cells propagated in cell-culture showed loss of contact inhi
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Ovarian Tumors in a Cohort of Infertile Women
Rossing, M. A., Daling, J. R., Weiss, N. S., Moore, D. E., & Self, S. G. (1994) · New England Journal of Medicine · doi:10.1056/nejm199409223311204 · Cited by 721
Cited by
Epidemiology of ovarian cancer: a review
Brett M., R., Brett M., R., Jennifer B., P., Thomas A., S., Jennifer B., P., & Thomas A., S. (2017) · Cancer Biology & Medicine · doi:10.20892/j.issn.2095-3941.2016.0084 · Cited by 1,524
Modan, B., Hartge, P., Hirsh-Yechezkel, G., Chetrit, A., Lubin, F., Beller, U., Ben-Baruch, G., Fishman, A., Menczer, J., Struewing, J. P., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200107263450401 · Cited by 385
Epidemiology of Ovarian Cancer
Permuth-Wey, J., & Sellers, T. A. (2009) · Methods in Molecular Biology · doi:10.1007/978-1-60327-492-0_20 · Cited by 326
Endometriosis and the risk of cancer with special emphasis on ovarian cancer
Melin, A., Sparén, P., Persson, I., & Bergqvist, A. (2006) · Human Reproduction · doi:10.1093/humrep/dei462 · Cited by 306
Self-citationFocus on epithelial ovarian cancer
Ozols, R. F., Bookman, M. A., Connolly, D. C., Daly, M. B., Godwin, A. K., Schilder, R. J., Xu, X., & Hamilton, T. C. (2004) · Cancer Cell · doi:10.1016/s1535-6108(04)00002-9 · Cited by 294
Metadata
- Authors
- Riman, T., Persson, I., & Nilsson, S.
- Venue
- Clinical Endocrinology
- Publisher
- Wiley
- Published
- 1998-12
- Volume
- 49
- Issue
- 6
- Pages
- 695-707
- ISSN
- 0300-0664 (ISSN-L)
- 1365-2265
- OpenAlex
- W2166473248
- Cited by
- 199
- References
- 1
- FWCI
- 9.57
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Hormonal aspects of epithelial ovarian cancer: review of epidemiological evidence. https://app.cochat.ai/papers/10.1046/j.1365-2265.1998.00577.x
- The paper
- Riman, T., Persson, I., & Nilsson, S. (1998). Hormonal aspects of epithelial ovarian cancer: review of epidemiological evidence. Clinical Endocrinology. https://doi.org/10.1046/j.1365-2265.1998.00577.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.